Stanford researchers discovered that dialing down an overactive enzyme, LRRK2, can regrow lost cellular “antennae” in key ...

A cancer immunotherapy may slow Parkinson’s disease by blocking the spread of harmful brain proteins, Johns Hopkins researchers found.

Putting the brakes on an enzyme might rescue neurons that are dying in Parkinson's disease, stabilizing the progression of ...

Putting the brakes on an enzyme might rescue neurons that are dying due to a type of Parkinson's disease that's caused by a ...

Inhibition of LKKR2 may rescue neurons that are dying due to a type of Parkinson’s disease that is caused by a single genetic mutation.

The results of experiments in mice models were "astounding," said biochemist Suzanne Pfeffer of Stanford University.

New research reveals Parkinson’s disease may originate in the kidneys, where toxic protein buildup travels to the brain—offering fresh hope for early detection and treatment.

Currently dopamine replacement medications, like levodopa and dopamine agonists, are the primary treatment for Parkinson's ...

Researchers have used magnetoencephalography brain imaging technology to determine how the drug levodopa, the main drug used ...